Needham Investment Management LLC Raises Holdings in Arteris, Inc. $AIP

Key Points

• Needham Investment Management LLC increased its holdings in Arteris, Inc. by 2.5%, owning nearly 6.78% of the company with a total value of approximately $19.43 million.
• Shares of Arteris have shown a 52-week range from $5.46 to $14.29, currently trading at $8.86, with a market capitalization of $377.88 million.
• Analysts have a consensus rating of "Buy" for Arteris with a target price of $15.00, reflecting positive growth expectations for the company.

Needham Investment Management LLC raised its holdings in Arteris, Inc. (NASDAQ:AIP - Free Report) by 2.5% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 2,812,500 shares of the company's stock after buying an additional 67,500 shares during the quarter. Arteris accounts for 1.8% of Needham Investment Management LLC's investment portfolio, making the stock its 14th largest holding. Needham Investment Management LLC owned about 6.78% of Arteris worth $19,434,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in AIP. Wells Fargo & Company MN lifted its stake in Arteris by 38.9% in the fourth quarter. Wells Fargo & Company MN now owns 13,192 shares of the company's stock valued at $134,000 after buying an additional 3,694 shares during the period. Barclays PLC lifted its stake in Arteris by 13.5% in the fourth quarter. Barclays PLC now owns 44,723 shares of the company's stock valued at $456,000 after buying an additional 5,327 shares during the period. Price T Rowe Associates Inc. MD acquired a new position in shares of Arteris during the fourth quarter worth approximately $117,000. Northern Trust Corp raised its position in shares of Arteris by 6.6% during the fourth quarter. Northern Trust Corp now owns 224,443 shares of the company's stock worth $2,287,000 after purchasing an additional 13,838 shares during the period. Finally, BNP Paribas Financial Markets acquired a new position in shares of Arteris during the fourth quarter worth approximately $214,000. 64.36% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, major shareholder Bayview Legacy, Llc sold 50,000 shares of the company's stock in a transaction on Tuesday, August 5th. The stock was sold at an average price of $13.12, for a total transaction of $656,000.00. Following the transaction, the insider owned 9,839,071 shares of the company's stock, valued at $129,088,611.52. This represents a 0.51% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Saiyed Atiq Raza sold 63,118 shares of the company's stock in a transaction on Tuesday, August 5th. The shares were sold at an average price of $13.07, for a total value of $824,952.26. Following the transaction, the director directly owned 590,000 shares in the company, valued at $7,711,300. This represents a 9.66% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 510,616 shares of company stock worth $5,979,663 over the last 90 days. Company insiders own 29.10% of the company's stock.

Arteris Stock Performance

NASDAQ:AIP traded up $0.19 during trading on Thursday, reaching $8.85. The company's stock had a trading volume of 156,139 shares, compared to its average volume of 548,639. The firm has a market cap of $377.24 million, a price-to-earnings ratio of -10.79 and a beta of 1.44. The firm has a 50 day moving average of $9.49 and a 200-day moving average of $8.22. Arteris, Inc. has a 12 month low of $5.46 and a 12 month high of $14.29.

Arteris (NASDAQ:AIP - Get Free Report) last announced its quarterly earnings data on Tuesday, August 5th. The company reported ($0.11) earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of ($0.11). The firm had revenue of $16.50 million during the quarter, compared to the consensus estimate of $16.35 million. Arteris had a negative return on equity of 8,546.17% and a negative net margin of 52.41%. Arteris has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Equities research analysts forecast that Arteris, Inc. will post -0.73 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on AIP. TD Cowen upped their target price on Arteris from $12.00 to $15.00 and gave the stock a "buy" rating in a research report on Wednesday, August 6th. Rosenblatt Securities reaffirmed a "buy" rating and set a $14.00 target price on shares of Arteris in a research report on Wednesday, May 21st. Finally, Wall Street Zen lowered Arteris from a "hold" rating to a "sell" rating in a research report on Sunday. Three equities research analysts have rated the stock with a Buy rating, According to MarketBeat.com, the company currently has a consensus rating of "Buy" and a consensus target price of $15.00.

Arteris Profile

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.